Novo Nordisk Extends Lead As Eli Lilly New Obesity Pill Sees Modest Launch Uptake

Reuters, citing IQVIA data, reported that Eli Lilly recorded 1,390 prescriptions for its newly launched obesity pill in the U.S. for the week ended April 10.